Claude LeBlanc, President and Chief Executive Officer, and David Trick, Executive Vice President and Chief Financial Officer, will discuss fourth quarter 2025 results during a live conference call. A ...

Octave Specialty Group, Inc. (NYSE: OSG), a global specialty insurance firm, will release fourth-quarter 2025 results on February 23, 2026, following the close of the market. On February 24, at 8:30am ...

A behavioral healthcare startup has snagged $11 million from investors as it seeks to expand service in New York and San Francisco and sharpen its ability to work with insurers. “Payers are ...

Octave Specialty Group's consensus analyst price target has recently increased from $14.67 to $16.33. This move is driven by higher expectations for the company. The upward revision is largely ...

Despite diverging from their techno roots, Octave One tell Danny Turner they’d sooner stop making music than sell their Roland TR-909 When you purchase through links on our site, we may earn an ...

MENLO PARK, Calif.--(BUSINESS WIRE)--Octave Bioscience, Inc., a commercial stage precision care company that is pioneering a new standard for managing multiple sclerosis (MS) and other ...

Fifty years ago today, Pope St. Paul VI wept. So goes the well-circulated — but not confirmed — story about Pope Paul going to his private chapel for Holy Mass on the Monday after Pentecost. He was ...

Octave Bioscience, a company focused on delivering precision medicine for neurodegenerative diseases like multiple sclerosis, announced it closed a $30 million extension to its Series B round. Hikma ...